Fisher Funds Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.3M Sell
304,933
-536,017
-64% -$44.6M 0.77% 38
2026
Q2
$56.6M Sell
840,950
-69,634
-8% -$4.64M 1.61% 11
2026
Q1
$57.2M Sell
910,584
-308,264
-25% -$21.5M 1.68% 14
2025
Q4
$81.1M Buy
1,218,848
+1,758
+0.1% +$114K 2.09% 11
2025
Q3
$81.9M Sell
1,217,090
-91,159
-7% -$7.21M 2.16% 11
2025
Q2
$114M Sell
1,308,249
-339,084
-21% -$26.6M 2.71% 10
2025
Q1
$112M Buy
1,647,333
+405,612
+33% +$33.1M 2.73% 10
2024
Q4
$96.5M Buy
+1,241,721
New +$91.9M 2.33% 12

Other funds holding DXCM

Fisher Funds Management's DXCM Position: Q3 2026 in Review

Fisher Funds Management reduced its DexCom (DXCM) stake by 64% in Q3 2026, selling an estimated $44.6M and leaving 304,933 shares worth $26.3M. The position accounts for 0.77% of the portfolio, ranked #38.

Fisher Funds Management first reported a position in DXCM in Q4 2024 and has held it in 8 quarters since. The position peaked at $114M in Q2 2025. 939 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Fisher Funds Management held 304,933 shares of DexCom worth $26.3M as of Q3 2026.
  • Fisher Funds Management sold 536,017 DexCom shares in Q3 2026, an estimated $44.6M.
  • DexCom made up 0.77% of Fisher Funds Management's portfolio in Q3 2026, its #38 holding.
  • Fisher Funds Management first reported a position in DexCom in Q4 2024 and has held it in 8 quarters since.
  • Fisher Funds Management's DexCom position peaked at $114M in Q2 2025.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Fisher Funds Management's 13F filing for Q3 2026, filed 13 Oct 2026.